Company: ADPT
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0000950170-25-103120
Chunk: 0

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-08-05
Form: 10-Q
Item: Item 1
Chunk 0
---
Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

     June 30, 2025

     December 31, 2024

     (unaudited)

     Assets

     Current assets

     Cash and cash equivalents
      
     $
     43,163

     $
     47,920

     Short-term marketable securities (amortized cost of $154,672 and $174,186, respectively)

     154,710

     174,374

     Accounts receivable, net

     44,285

     41,731

     Inventory, net

     8,403

     8,440

     Prepaid expenses and other current assets

     11,295

     11,287

     Total current assets

     261,856

     283,752

     Long-term assets

     Property and equipment, net

     41,055

     48,616

     Operating lease right-of-use assets

     43,338

     45,767

     Long-term marketable securities (amortized cost of $24,065 and $33,682, respectively)

     24,100

     33,660

     Restricted cash

     2,720

     2,897

     Intangible assets, net

     2,583

     3,425

     Goodwill

     118,972

     118,972

     Other assets

     2,013

     2,287

     Total assets
      
     $
     496,637

     $
     539,376

     Liabilities and shareholders’ equity

     Current liabilities

     Accounts payable
      
     $
     6,908

     $
     7,265

     Accrued liabilities

     7,205

     8,157

     Accrued compensation and benefits

     9,700

     15,838

     Current portion of operating lease liabilities

     9,957

     10,239

     Current portion of deferred revenue

     55,301

     55,689

     Current portion of revenue interest liability, net

     3,070

     865

     Total current liabilities

     92,141

     98,053

     Long-term liabilities

     Operating lease liabilities, less